Close Menu

NEW YORK — The US Food and Drug Administration last week granted Emergency Use Authorization to a SARS-CoV-2 antibody test developed by Chinese biotechnology firm Innovita Biological Technology.

The Innovita 2019-nCoV Ab Test (Colloidal Gold) is a rapid lateral flow chromatographic immunoassay designed to detect immunoglobulin M and immunoglobulin G against SARS-CoV-2 in serum, plasma, and whole blood samples. Test results are provided within 10 to 15 minutes, according to Innovita.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.